{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:58:28Z","timestamp":1783763908415,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Medical and Health Science and Technology Plan Project","award":["2022KY1182"],"award-info":[{"award-number":["2022KY1182"]}]},{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","award":["2017A610276"],"award-info":[{"award-number":["2017A610276"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Project of Agriculture and Social Science of Ningbo Yinzhou District","award":["2021AS0053"],"award-info":[{"award-number":["2021AS0053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-024-02065-2","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T02:01:52Z","timestamp":1728957712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["High levels of serum hypersensitive C-reactive protein are associated with non-alcoholic fatty liver disease in non-obese people: a cross-sectional study"],"prefix":"10.1186","volume":"29","author":[{"given":"Guitao","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9610-1943","authenticated-orcid":false,"given":"Changxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"issue":"7","key":"2065_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","volume":"110","author":"P Kasper","year":"2021","unstructured":"Kasper P, Martin A, Lang S, et al. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2021;110(7):921\u201337. https:\/\/doi.org\/10.1007\/s00392-020-01709-7.","journal-title":"Clin Res Cardiol"},{"issue":"2022","key":"2065_CR2","first-page":"4709300","volume":"18","author":"C Chen","year":"2022","unstructured":"Chen C, Li H, Song J, et al. Role of apolipoprotein A1 in PPAR signaling pathway for nonalcoholic fatty liver disease. PPAR Res. 2022;18(2022):4709300.","journal-title":"PPAR Res"},{"issue":"5","key":"2065_CR3","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/ijms17050774","volume":"17","author":"L Calzadilla Bertot","year":"2016","unstructured":"Calzadilla Bertot L, Adams LA. The natural course of non-alcoholic fatty liver disease. Int J Mol Sci. 2016;17(5):774.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2065_CR4","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou F, Wang W, et al. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology. 2020;71(5):1851\u201364. https:\/\/doi.org\/10.1002\/hep.31150.","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"2065_CR5","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47-64. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012.","journal-title":"J Hepatol"},{"issue":"2","key":"2065_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","volume":"76","author":"F Foerster","year":"2022","unstructured":"Foerster F, Gairing SJ, M\u00fcller L, et al. NAFLD-driven HCC: safety and efficacy of current and emerging treatment options. J Hepatol. 2022;76(2):446\u201357. https:\/\/doi.org\/10.1016\/j.jhep.2021.09.007.","journal-title":"J Hepatol"},{"issue":"10","key":"2065_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1872-034X.2011.00867.x","volume":"41","author":"K Sugimoto","year":"2011","unstructured":"Sugimoto K, Takei Y. Clinicopathological features of non-alcoholic fatty liver disease. Hepatol Res. 2011;41(10):911\u201320. https:\/\/doi.org\/10.1111\/j.1872-034X.2011.00867.x.","journal-title":"Hepatol Res"},{"issue":"7","key":"2065_CR8","first-page":"221","volume":"5","author":"A Berlanga","year":"2014","unstructured":"Berlanga A, Guiu-Jurado E, Porras JA, et al. Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol. 2014;5(7):221\u201339.","journal-title":"Clin Exp Gastroenterol"},{"issue":"11","key":"2065_CR9","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/ijms21113863","volume":"21","author":"H Fujii","year":"2020","unstructured":"Fujii H, Kawada N, Japan Study Group of Nafld Jsg-Nafld. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol Sci. 2020;21(11):3863. https:\/\/doi.org\/10.3390\/ijms21113863.","journal-title":"Int J Mol Sci"},{"issue":"2020","key":"2065_CR10","first-page":"3920196","volume":"31","author":"DM Tanase","year":"2020","unstructured":"Tanase DM, Gosav EM, Costea CF, et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res. 2020;31(2020):3920196.","journal-title":"J Diabetes Res"},{"key":"2065_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021;50: 101238. https:\/\/doi.org\/10.1016\/j.molmet.2021.101238.","journal-title":"Mol Metab."},{"issue":"9","key":"2065_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/nu9090981","volume":"9","author":"KW Ter Horst","year":"2017","unstructured":"Ter Horst KW, Serlie MJ. Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease. Nutrients. 2017;9(9):981. https:\/\/doi.org\/10.3390\/nu9090981.","journal-title":"Nutrients"},{"issue":"6","key":"2065_CR13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1440-1746.2004.03362.x","volume":"19","author":"SH Park","year":"2004","unstructured":"Park SH, Kim BI, Yun JW, et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol. 2004;19(6):694\u20138. https:\/\/doi.org\/10.1111\/j.1440-1746.2004.03362.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"2065_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3760\/cma.j.issn.1007-3418.2010.03.002","volume":"18","author":"The Fatty Liver and Alcoholic Liver Disease Group of the Chinese Medical Association, Branch of Hepatology","year":"2010","unstructured":"The Fatty Liver and Alcoholic Liver Disease Group of the Chinese Medical Association, Branch of Hepatology. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition (2010 Revision). Chin J Liver Dis. 2010;18(3):163\u20136. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2010.03.002.","journal-title":"Chin J Liver Dis"},{"issue":"2","key":"2065_CR15","doi-asserted-by":"publisher","first-page":"2294933","DOI":"10.1080\/07853890.2023.2294933","volume":"55","author":"P Qiu","year":"2023","unstructured":"Qiu P, Du J, Zhang C, Li M, et al. Increased risk of reflux esophagitis in non-obese individuals with nonalcoholic fatty liver disease: a cross-sectional study. Ann Med. 2023;55(2):2294933. https:\/\/doi.org\/10.1080\/07853890.2023.2294933.","journal-title":"Ann Med"},{"issue":"2","key":"2065_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1684\/abc.2017.1232","volume":"75","author":"M Moutachakkir","year":"2017","unstructured":"Moutachakkir M, LamraniHanchi A, Baraou A, et al. Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein. Ann Biol Clin (Paris). 2017;75(2):225\u20139. https:\/\/doi.org\/10.1684\/abc.2017.1232.","journal-title":"Ann Biol Clin (Paris)."},{"issue":"38","key":"2065_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034638","volume":"102","author":"X Wang","year":"2023","unstructured":"Wang X, Zhao D, Cheng L, et al. Mendelian randomization explores the causal relationships between obesity, diabetes, inflammation and nonalcoholic fatty liver disease. Medicine (Baltimore). 2023;102(38): e34638. https:\/\/doi.org\/10.1097\/MD.0000000000034638.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2065_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4103\/jfmpc.jfmpc_887_19","volume":"9","author":"R Kumar","year":"2020","unstructured":"Kumar R, Porwal YC, Dev N, et al. Association of high-sensitivity C-reactive protein (hs-CRP) with non-alcoholic fatty liver disease (NAFLD) in Asian Indians: a cross-sectional study. J Fam Med Prim Care. 2020;9(1):390\u20134. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_887_19.","journal-title":"J Fam Med Prim Care"},{"issue":"3","key":"2065_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.advnut.2023.01.001","volume":"14","author":"RL Hall","year":"2023","unstructured":"Hall RL, George ES, Tierney AC, et al. Effect of dietary intervention, with or without cointerventions, on inflammatory markers in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Adv Nutr. 2023;14(3):475\u201399. https:\/\/doi.org\/10.1016\/j.advnut.2023.01.001.","journal-title":"Adv Nutr"},{"issue":"130","key":"2065_CR20","first-page":"422","volume":"61","author":"AO Yeniova","year":"2014","unstructured":"Yeniova AO, K\u00fc\u00e7\u00fckazman M, Ata N, et al. High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease. Hepatogastroenterology. 2014;61(130):422\u20135.","journal-title":"Hepatogastroenterology"},{"issue":"50","key":"2065_CR21","doi-asserted-by":"publisher","first-page":"29495","DOI":"10.18632\/oncotarget.25685","volume":"9","author":"J Nguyen","year":"2018","unstructured":"Nguyen J, Jiao J, Smoot K, et al. Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. Oncotarget. 2018;9(50):29495\u2013507. https:\/\/doi.org\/10.18632\/oncotarget.25685.","journal-title":"Oncotarget"},{"key":"2065_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbi.2018.02.013","volume":"70","author":"M Del Giudice","year":"2018","unstructured":"Del Giudice M, Gangestad SW. Rethinking IL-6 and CRP: why they are more than inflammatory biomarkers, and why it matters. Brain Behav Immun. 2018;70:61\u201375. https:\/\/doi.org\/10.1016\/j.bbi.2018.02.013.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"2065_CR23","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41467-017-02325-2","volume":"8","author":"SY Kim","year":"2017","unstructured":"Kim SY, Jeong JM, Kim SJ, et al. Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex. Nat Commun. 2017;8(1):2247. https:\/\/doi.org\/10.1038\/s41467-017-02325-2.","journal-title":"Nat Commun"},{"issue":"43","key":"2065_CR24","doi-asserted-by":"publisher","first-page":"16067","DOI":"10.1021\/acs.jafc.3c02337","volume":"71","author":"F Guo","year":"2023","unstructured":"Guo F, Xiong H, Tsao R, et al. Green pea (Pisum sativum L.) hull polyphenol extract alleviates NAFLD through VB6\/TLR4\/NF-\u03baB and PPAR pathways. J Agric Food Chem. 2023;71(43):16067\u201378. https:\/\/doi.org\/10.1021\/acs.jafc.3c02337.","journal-title":"J Agric Food Chem"},{"key":"2065_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10622-w","author":"H Wu","year":"2024","unstructured":"Wu H, Zhou M, Jin Q, et al. The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK\/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease. Hepatol Int. 2024. https:\/\/doi.org\/10.1007\/s12072-023-10622-w.","journal-title":"Hepatol Int"},{"issue":"2021","key":"2065_CR26","doi-asserted-by":"publisher","first-page":"6642246","DOI":"10.1155\/2021\/6642246","volume":"7","author":"H Huang","year":"2021","unstructured":"Huang H, Wang Q, Shi X, et al. Association between monocyte to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: a cross-sectional study. Mediators Inflamm. 2021;7(2021):6642246. https:\/\/doi.org\/10.1155\/2021\/6642246.","journal-title":"Mediators Inflamm"},{"issue":"11","key":"2065_CR27","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","volume":"72","author":"E En Li Cho","year":"2023","unstructured":"En Li Cho E, Ang CZ, Quek J, et al. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut. 2023;72(11):2138\u201348. https:\/\/doi.org\/10.1136\/gutjnl-2023-330110.","journal-title":"Gut"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-02065-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T02:05:37Z","timestamp":1728957937000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-02065-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2065"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-02065-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,15]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committees of Zhenhai Lianhua Hospital. The informed consents were obtained from the objects (decision no. 20120213).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"496"}}